ARISTO — Aristo Bio-Tech and Lifescience Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsHighly SpeculativeMicro CapNeutral

Annual balance sheet for Aristo Bio-Tech and Lifescience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	5.25	1.12	4.16	18.5	6.37
Net Total Accounts Receivable
Net Total Receivables	519	370	378	498	638
Total Inventory
Total Other Current Assets
Total Current Assets	767	691	625	831	1,050
Net Property, Plant And Equipment	111	123	145	167	217
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	879	814	770	998	1,273
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	649	560	510	595	836
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	755	680	622	697	937
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	123	134	148	302	336
Total Liabilities & Shareholders' Equity	879	814	770	998	1,273
Total Common Shares Outstanding